GAO Finds Eight Days Insufficient for FPR Response
Client Alert | 1 min read | 12.03.19
In a recently published decision, MCR Federal, LLC, GAO sustained a protest challenging the required response date for final proposal revisions in a task order procurement. Specifically, as part of its voluntary corrective action in response to an earlier post award protest by MCR, the agency issued MCR two “interchange notices” stating concerns related to experience levels and the contingent-hire nature of the majority of MCR’s proposed staffing, and permitting MCR two days to “either revise or confirm” its proposal. MCR again protested that the allotted two days were insufficient. In response, the agency extended the deadline to a total of eight days and then moved to dismiss. GAO declined to dismiss. Instead, it sustained MCR’s protest, finding eight days insufficient to provide MCR a fair opportunity to improve its proposal. Subsequently, GAO dismissed the agency’s reconsideration request and declined to recommend a specific time period for final proposal revisions.
Contacts
Insights
Client Alert | 2 min read | 02.03.26
CMS Doubles Down on RADV Audit Changes
On January 27, 2026, the Centers for Medicare and Medicaid Services (CMS) released a Health Plan Management System (HPMS) memo that provided a long-awaited update on how the agency plans to approach previously announced Risk Adjustment Data Validation (RADV) audits for Payment Years (PY) 2020-2024. The memo is the agency’s most comprehensive statement on the subject since September 25, 2025, when the Northern District of Texas vacated the 2023 RADV Final Rule. The memo makes clear that, while CMS has made certain operational adjustments in response to concerns expressed by Medicare Advantage Organizations (MAOs), the agency is largely pressing forward with the accelerated audit strategy announced in May 2025.
Client Alert | 2 min read | 02.03.26
Sedona Model Jury Instructions for DTSA: A Step Forward—But Questions Remain
Client Alert | 7 min read | 01.30.26
CMS Proposes CY 2027 Growth Rate and Changes to Risk Adjustment for Medicare Parts C and D
Client Alert | 4 min read | 01.30.26
Optimum’s Shot Across the Bow: An Antitrust Challenge to Cooperation Agreements
